Si-yang M. Liu
The Clinical Medicine Postdoctoral Research Station
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
FUS inactivation promotes leptomeningeal metastasis of lung cancer through the up-regulation of CD36.
Journal: Science translational medicine
Published: August 26, 2026
Representation Learning for Tabular Data: A Comprehensive Survey.
Journal: IEEE transactions on pattern analysis and machine intelligence
Published: January 30, 2026
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer.
Journal: Lung Cancer (Auckland, N.Z.)
Published: January 16, 2026
LAMPAD: An Integrated Circulating Tumor DNA-Based Model for Predicting Potential Cure in Patients With Resected NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 21, 2025
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases.
Journal: Journal for immunotherapy of cancer
Published: October 26, 2025
Co-expression pattern of CD8, CXCR5 and CXCL13 in tumor microenvironment predicts favorable efficacy of immunotherapy in lung adenocarcinoma.
Journal: European journal of pharmacology
Published: September 12, 2025
Live biotherapeutic enterococcus lactis MNC-168 promotes the efficacy of immune checkpoint blockade in cancer therapy by activating STING pathway via bacterial membrane vesicles.
Journal: Gut microbes
Published: September 12, 2025
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study.
Journal: The Lancet. Oncology
Published: July 02, 2025
Comparison of astigmatism correction after limbal relaxing incisions combined with ICL implantation and Toric ICL implantation in patients with high myopia
Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology
Published: June 08, 2025
A Patient-Centric, Open-Label, Multicenter, Phase II Study of Lorlatinib Monotherapy in the First-Line Treatment of Patients With locally Advanced or Metastatic ALK-Positive Non-Small Cell Lung Cancer (CTONG2203).
Journal: Clinical lung cancer
Published: January 22, 2025
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 12, 2024
Last Updated: 09/26/2026